Investigating Chinese Herbal Medicine for Modulating Gut Microbiota in Treating Inflammatory Bowel Disease: Molecular Mechanisms and Clinical Study

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 27, 2024

Primary Completion Date

June 6, 2025

Study Completion Date

June 6, 2025

Conditions
IBD - Inflammatory Bowel Disease
Interventions
DRUG

BXD treatment

The BXD extract was obtained from Sun Ten Pharmaceutical Company and is manufactured according to the standard procedures outlined in the Taiwan Herbal Pharmacopeia IV. The extract is produced using a fixed herbal composition and ratio based on the traditional BXD formula to yield a concentrated powder. The administration of BXD in this study follows the dosage and usage guidelines specified in the Pharmacopeia.

Trial Locations (1)

40447

China medicial university hospital, Taichung

All Listed Sponsors
lead

China Medical University Hospital

OTHER

NCT07035613 - Investigating Chinese Herbal Medicine for Modulating Gut Microbiota in Treating Inflammatory Bowel Disease: Molecular Mechanisms and Clinical Study | Biotech Hunter | Biotech Hunter